Skip to Main Content
Back to News

CARDLYTICS Earnings Results: $CDLX Reports Quarterly Earnings

None

CARDLYTICS ($CDLX) posted quarterly earnings results on Wednesday, March 12th. The company reported earnings of $0.00 per share, beating estimates of -$0.18 by $0.18. The company also reported revenue of $74,000,000, beating estimates of $64,899,713 by $9,100,287.

You can see Quiver Quantitative's $CDLX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

CARDLYTICS Insider Trading Activity

CARDLYTICS insiders have traded $CDLX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $CDLX stock by insiders over the last 6 months:

  • AMIT GUPTA (Chief Executive Officer) has made 0 purchases and 6 sales selling 152,696 shares for an estimated $524,173.
  • ALEXIS DESIENO (Chief Financial Officer) has made 0 purchases and 4 sales selling 66,237 shares for an estimated $225,915.
  • CLIFFORD SOSIN has made 0 purchases and 3 sales selling 50,823 shares for an estimated $195,245.
  • NICHOLAS HOLLMEYER LYNTON (Chief Legal & Privacy Officer) has made 0 purchases and 3 sales selling 15,777 shares for an estimated $52,792.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CARDLYTICS Hedge Fund Activity

We have seen 54 institutional investors add shares of CARDLYTICS stock to their portfolio, and 76 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles